Related Experiment Videos
Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases
Insights
Combining verapamil with beta-adrenergic blockers can cause severe cardiac issues like heart failure and low blood pressure in patients with ischemic heart disease. Discontinuing this combination therapy led to complete recovery, highlighting potential drug interaction risks.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- Ischemic heart disease management often involves multiple medications.
- Verapamil and beta-adrenergic blockers are commonly prescribed for cardiovascular conditions.
- Understanding drug interactions is crucial for patient safety.
Observation:
- Three patients with ischemic heart disease experienced severe cardiac failure, hypotension, and bradycardia.
- These adverse events occurred during concurrent therapy with verapamil and beta-adrenergic blocking agents.
- Symptoms resolved fully upon discontinuation of the combined drug regimen.
Findings:
- Simultaneous administration of verapamil and beta-adrenergic blockers can lead to profound adverse cardiovascular interactions.
- Even patients with normal or mildly reduced baseline left ventricular function were susceptible.
- The combination therapy poses a significant risk of acute cardiac decompensation.
Implications:
- Clinicians should exercise extreme caution when prescribing verapamil and beta-adrenergic blockers together.
- Careful patient monitoring is essential during combined therapy.
- This interaction necessitates a re-evaluation of current treatment guidelines for specific patient populations.
Abstract:
Three patients with ischaemic heart disease developed profound cardiac failure, hypotension and bradycardia during combined therapy with verapamil and beta-adrenergic blocking drugs. This clinical picture resolved completely with cessation of the combined therapy. Baseline left ventricular function, assessed by cardiac catheterisation or nuclear angiography, was normal in two patients and only mildly reduced in the other. Simultaneously administration of beta-adrenergic blocking drugs and verapamil may result in profound adverse interactions and should only be administered with great caution.